Axial Healthcare buys Mayo startup mRemedy

Raleigh, N.C.-based care coordination systems vendor Axial Healthcare snapped up the Mayo Clinic's in-house-developed mRemedy suite of products, the company announced last week. The mRemedy system--specifically its myTality segment--allows patients to navigate the post-discharge process, obtain health information, manage follow-up visits and even receive personalized care plans, according to the company.

Mayo developed the system over the past three years with vendor DoApp, and last year won the Office of the National Coordinator for Health IT's "Ensuring Safe Transitions from Hospital to Home" mobile app contest for the product. Mayo will populate the mRemedy system with its library of medical content covering 1,000 conditions, allowing patients to search symptoms, follow-up care, etc.

Axial brings expertise in electronic health record development to the table, according to a story at MedCity News.

The deal isn't the end of the road for Mayo and mRemedy, though. Four Mayo physicians will join Axial's advisory board to continue development of the product suite. In addition, as part of the deal, both Mayo and Axial's primary investor, Canaan Partners, upped its investment in the company, though the amount remains undisclosed.

To learn more:
- read the MedCity News article
- check out Axial's announcement

Suggested Articles

The newly launched Center for Connected Health will be largest telehealth hub in the Philadelphia region, according to Penn Medicine.

The FDA commissioner wants to use additional funding under Trump's budget to advance digital health initiatives and integrate real-world data.

The FDA's approval of an app that uses AI to notify specialists of a potential stroke offers new possibilities for triage software that uses CDS.